27 8 
Home Page  

  • SciELO


Oncología (Barcelona)

 ISSN 0378-4835

BOSCH ROIG, C. et al. Colorectal adenocarcinoma: survival prognostic factors of the adjuvant treatment with 5-fluorouracil-levamisole (5FU-Lev). []. , 27, 8, pp.26-34. ISSN 0378-4835.

PURPOSE: To assess the overall survival and the 5-year disease-free survival, and to investigate the prognostic factors of patients with stages II and III colorectal adenocarcinoma subjected to healing-intention surgery and adjuvant chemotherapy with 5-fluorouracil-levamisole (5-FU-LEV). MATERIAL AND METHODS: A cohort of 126 patients treated with 5-FU-LEV during 12 months were studied between September 1990 and November 1997. RESULTS: The number of infiltrated lymph nodes, and the vascular-lymphatic and perineural invasion were found to be significant prognostic factors in the mean overall survival and disease-free survival after 5 years. Bowel obstruction showed prognostic significance only in relation to the 5-year disease-free survival. CONCLUSIONS: The obtained results are similar to those reported in other large series published in the literature related with overall survival, disease-free survival and prognostic factors. Infiltrated lymph nodes remain as a significant prognostic factor in multivariate analysis.

: Colon cancer; Rectal cancer; Adjuvant chemotherapy; Prognosis study.

        · |     · |     · ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License